
Acadia Healthcare (ACHC) Stock Forecast & Price Target
Acadia Healthcare (ACHC) Analyst Ratings
Bulls say
Acadia Healthcare Co Inc is positioned favorably due to its strong performance in the behavioral health sector, marked by significant organic growth through bed expansions and new developments, alongside robust capitalization for potential mergers and acquisitions. The company anticipates substantial growth in both revenue—targeting 9-11% organic growth—and EBITDA, forecasting an increase of 10-12% from 2024 to 2028, which reflects an optimistic operational outlook. With potential improvements at underperforming facilities and a projected rise in Medicaid payments, Acadia's strategic initiatives and long-term growth targets suggest a positive trajectory for financial performance.
Bears say
Acadia Healthcare Co Inc. has faced a challenging outlook, with weaker-than-expected performance in 2024 leading to a downward revision in its 2025 guidance, resulting in EBITDA projections 10% below previous estimates. The company’s long-term margin target has also been adjusted downward, forecasting an EBITDA margin of 21.7% in 2028, a decline from 22.5% in 2024, further indicating deteriorating profitability expectations. Additionally, the enterprise multiple has contracted significantly to approximately 6.6x forward EBITDA, starkly lower than historical averages, reflecting growing investor concerns about Acadia's revenue growth and margin trajectory.
This aggregate rating is based on analysts' research of Acadia Healthcare and is not a guaranteed prediction by Public.com or investment advice.
Acadia Healthcare (ACHC) Analyst Forecast & Price Prediction
Start investing in Acadia Healthcare (ACHC)
Order type
Buy in
Order amount
Est. shares
0 shares